Why this choice matters
Specifiers keep bumping into the same snag: pick an off-the-shelf (COTS) tray and save time — or commission a custom tray that actually survives gamma sterilization and passes residual ethylene oxide (EO) checks. I saw this exact split at Medtec China during a medical device expo in Shanghai — suppliers jockeying with engineers over material declarations and test data. The decision touches sterilization validation, product safety, and supplier risk all at once, so you need a tight checklist before signing contracts.
Top risks with COTS trays
COTS looks fast and cheap but hides problems. Unknown polymer blends can break down under gamma irradiation, creating extractables that hold onto EO or produce new volatile residues. Bioburden control gets messy when tray geometry traps contaminants. And often the datasheet stops short of sterilization-specific residuals testing, leaving you with post-sterilization surprises. These are real supply-chain pitfalls that slow time-to-market.
When a custom tray is worth it
Custom tooling lets you control resin grade, wall thickness, and venting so gamma irradiation doesn’t compromise the part. You can specify material compatibility, request validated sterilization cycles, and demand residuals testing as part of acceptance. It costs more upfront — but you cut downstream surprises. — And if your device needs strict residual EO limits or tight dimensional tolerances after sterilization, custom usually pays back fast.
Practical verification steps for residual EO (what to ask for)
Don’t rely on vendor claims alone. Require these checks before approval: material certificates that state polymer family and additives; post-sterilization residuals testing reports (showing ethylene oxide measurements); and sterilization validation evidence for your cycle. Lab methods commonly used include headspace gas analysis for volatiles and targeted residuals testing — make sure the report lists sampling date, lot number, and detection limits. Also confirm how the tray was conditioned after sterilization before sampling, since temperature and aeration change residuals results.
Common testing and acceptance evidence to request
Ask suppliers to provide: batch-level material declaration, post-sterilization residuals report with method and limit of detection, and sterilization cycle validation summary referencing the actual dose and dwell parameters. If they offer retention samples or lot-based verification, note the storage conditions and how long samples were held prior to analysis — that protects future audits.
Common mistakes teams make
Avoid these traps:
– Taking vendor “gamma-stable” claims at face value without seeing post-sterilization data.
– Missing the chemistry: additives or colorants can trap EO or form reactive byproducts.
– Skipping lot-based verification after design freeze — one good report at R&D doesn’t guarantee each production lot behaves the same.
Cost versus risk — a short comparison
COTS: lower capex, faster supplier lead time, higher risk of missing residuals data and unexpected rework. Custom: higher upfront cost, longer lead time, lower technical and regulatory risk if you lock material specs and testing into procurement. Choose by tolerance for rework, regulatory profile, and sterilization method — gamma irradiation and ethylene oxide interact differently with polymers, so align choices to your sterilization validation plan.
Golden rules — 3 critical metrics to evaluate suppliers
1) Residuals Traceability: supplier provides a lot-specific post-sterilization residuals report showing method, limit of detection, and sample conditioning.
2) Material Transparency: full polymer family and additive declaration with evidence of gamma stability (post-dose mechanical or chemical checks).
3) Sterilization Alignment: sterilization validation summary tied to your device’s cycle (dose, dwell, aeration practices) and demonstrated via residuals testing on production-equivalent parts.
Wrap and next step
Specifiers who insist on those three metrics cut regulatory friction and avoid product delays. Use procurement language that makes testing and lot traceability contractual. If you still need options, shortlist a few trusted COTS vendors but require a pilot batch test; or get one custom tool built and validate it comprehensively — either path works if you stick to the metrics above. Learnings from shows like Medtec help you spot suppliers who actually bring lab data, not just sales slides — and that’s the edge your team needs. Medtec.